Safety of ENC-201-CED ENCRT
Diabetes Mellitus, Type 1The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
18 to 70
Participation Criteria
Inclusion Criteria:
* Candidates must satisfy site's eligibility for standard of care islet infusion.
Exclusion Criteria:
* Candidates are excluded based on the site's criteria for standard of care islet infusion.
Study Location
McGill University Health Centre
McGill University Health CentreMontréal, Quebec
Canada
Contact Study Team
Primary Contact
Lin Jawhar
- Study Sponsored By
- Encellin
- Participants Required
- More Information
- Study ID:
NCT06408311